#evusheld2

Live, measured metrics for the hashtag #evusheld2 from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #evusheld2

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$51.02/ year · 9-character #name
Claim #evusheld2$51.02/yrBuy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
1
Recent posts
Mastodon
Recent pace
Mastodon · last 1
0
Avg reactions / post
Mastodon · last 1
Reddit posts / month
Reddit search
Open-web mentions
hashtag.org Firehose

Day-by-day usage

measured · fosstodon.org (Mastodon public tags API) · fetched 2026-08-12 09:47 UTC
0
08-06
0
08-07
0
08-08
0
08-09
0
08-10
0
08-11
0
08-12

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · fosstodon.org (Mastodon public search API) · fetched 2026-08-12 09:47 UTC

No related tags with measured usage found for #evusheld2.

Live pulse

measured · fosstodon.org (Mastodon tag timeline) · fetched 2026-08-12 09:47 UTC

Everything below is measured over the latest 1 public posts.

Posting hours (UTC)

00:0012:0023:00

Languages: English (1)

Avg boosts / post: 0

Used together with

No co-used tags in the sample.

Top of the latest posts

  • Trial on #Evusheld2 in the US🇺🇸 for age 12yrs+ (NB/ not recruiting yet): https://clinicaltrials.gov/ct2/show/NCT05648110

    Clinically Vulnerable Families@[email protected]002022-12-15 13:35 UTCView post →

What “evusheld2” means

Wikipedia

Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19. It is being developed by British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca. It is co-packaged and given as two separate consecutive intramuscular injections.

Tixagevimab/cilgavimab” on Wikipedia (CC BY-SA) →

#evusheld2 across platforms

every network with a public tag surface

Follow #evusheld2 straight to each platform’s own tag page. Where a platform publishes open data we measure it above; the rest lock their numbers behind paid APIs, so we link rather than guess.

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/evusheld2